Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 5:44 pm | N/A 2034-03-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:33 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 157,324 | $0 | 157,324 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:33 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 370,626 | $0 | 157,324 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:08 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:12 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:15 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 46,000 | $0 | 46,000 (Direct) | View |
Ownership | 2022-05-06 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 0 | $0 | 515,478 (Indirect) | View |